Cargando…

A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation

Epidermal homeostasis relies on a well-defined transcriptional control of keratinocyte proliferation and differentiation, which is critical to prevent skin diseases such as atopic dermatitis, psoriasis or cancer. We have recently shown that the homeobox transcription factor DLX3 and the tumor suppre...

Descripción completa

Detalles Bibliográficos
Autores principales: Palazzo, Elisabetta, Kellett, Meghan D, Cataisson, Christophe, Bible, Paul W, Bhattacharya, Shreya, Sun, Hong-wei, Gormley, Anna C, Yuspa, Stuart H, Morasso, Maria I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384032/
https://www.ncbi.nlm.nih.gov/pubmed/28186503
http://dx.doi.org/10.1038/cdd.2017.5
_version_ 1782520391063830528
author Palazzo, Elisabetta
Kellett, Meghan D
Cataisson, Christophe
Bible, Paul W
Bhattacharya, Shreya
Sun, Hong-wei
Gormley, Anna C
Yuspa, Stuart H
Morasso, Maria I
author_facet Palazzo, Elisabetta
Kellett, Meghan D
Cataisson, Christophe
Bible, Paul W
Bhattacharya, Shreya
Sun, Hong-wei
Gormley, Anna C
Yuspa, Stuart H
Morasso, Maria I
author_sort Palazzo, Elisabetta
collection PubMed
description Epidermal homeostasis relies on a well-defined transcriptional control of keratinocyte proliferation and differentiation, which is critical to prevent skin diseases such as atopic dermatitis, psoriasis or cancer. We have recently shown that the homeobox transcription factor DLX3 and the tumor suppressor p53 co-regulate cell cycle-related signaling and that this mechanism is functionally involved in cutaneous squamous cell carcinoma development. Here we show that DLX3 expression and its downstream signaling depend on protein kinase C α (PKCα) activity in skin. We found that following 12-O-tetradecanoyl-phorbol-13-acetate (TPA) topical treatment, DLX3 expression is significantly upregulated in the epidermis and keratinocytes from mice overexpressing PKCα by transgenic targeting (K5-PKCα), resulting in cell cycle block and terminal differentiation. Epidermis lacking DLX3 (DLX3cKO), which is linked to the development of a DLX3-dependent epidermal hyperplasia with hyperkeratosis and dermal leukocyte recruitment, displays enhanced PKCα activation, suggesting a feedback regulation of DLX3 and PKCα. Of particular significance, transcriptional activation of epidermal barrier, antimicrobial peptide and cytokine genes is significantly increased in DLX3cKO skin and further increased by TPA-dependent PKC activation. Furthermore, when inhibiting PKC activity, we show that epidermal thickness, keratinocyte proliferation and inflammatory cell infiltration are reduced and the PKC-DLX3-dependent gene expression signature is normalized. Independently of PKC, DLX3 expression specifically modulates regulatory networks such as Wnt signaling, phosphatase activity and cell adhesion. Chromatin immunoprecipitation sequencing analysis of primary suprabasal keratinocytes showed binding of DLX3 to the proximal promoter regions of genes associated with cell cycle regulation, and of structural proteins and transcription factors involved in epidermal differentiation. These results indicate that Dlx3 potentially regulates a set of crucial genes necessary during the epidermal differentiation process. Altogether, we demonstrate the existence of a robust DLX3–PKCα signaling pathway in keratinocytes that is crucial to epidermal differentiation control and cutaneous homeostasis.
format Online
Article
Text
id pubmed-5384032
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53840322017-04-21 A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation Palazzo, Elisabetta Kellett, Meghan D Cataisson, Christophe Bible, Paul W Bhattacharya, Shreya Sun, Hong-wei Gormley, Anna C Yuspa, Stuart H Morasso, Maria I Cell Death Differ Original Paper Epidermal homeostasis relies on a well-defined transcriptional control of keratinocyte proliferation and differentiation, which is critical to prevent skin diseases such as atopic dermatitis, psoriasis or cancer. We have recently shown that the homeobox transcription factor DLX3 and the tumor suppressor p53 co-regulate cell cycle-related signaling and that this mechanism is functionally involved in cutaneous squamous cell carcinoma development. Here we show that DLX3 expression and its downstream signaling depend on protein kinase C α (PKCα) activity in skin. We found that following 12-O-tetradecanoyl-phorbol-13-acetate (TPA) topical treatment, DLX3 expression is significantly upregulated in the epidermis and keratinocytes from mice overexpressing PKCα by transgenic targeting (K5-PKCα), resulting in cell cycle block and terminal differentiation. Epidermis lacking DLX3 (DLX3cKO), which is linked to the development of a DLX3-dependent epidermal hyperplasia with hyperkeratosis and dermal leukocyte recruitment, displays enhanced PKCα activation, suggesting a feedback regulation of DLX3 and PKCα. Of particular significance, transcriptional activation of epidermal barrier, antimicrobial peptide and cytokine genes is significantly increased in DLX3cKO skin and further increased by TPA-dependent PKC activation. Furthermore, when inhibiting PKC activity, we show that epidermal thickness, keratinocyte proliferation and inflammatory cell infiltration are reduced and the PKC-DLX3-dependent gene expression signature is normalized. Independently of PKC, DLX3 expression specifically modulates regulatory networks such as Wnt signaling, phosphatase activity and cell adhesion. Chromatin immunoprecipitation sequencing analysis of primary suprabasal keratinocytes showed binding of DLX3 to the proximal promoter regions of genes associated with cell cycle regulation, and of structural proteins and transcription factors involved in epidermal differentiation. These results indicate that Dlx3 potentially regulates a set of crucial genes necessary during the epidermal differentiation process. Altogether, we demonstrate the existence of a robust DLX3–PKCα signaling pathway in keratinocytes that is crucial to epidermal differentiation control and cutaneous homeostasis. Nature Publishing Group 2017-04 2017-02-10 /pmc/articles/PMC5384032/ /pubmed/28186503 http://dx.doi.org/10.1038/cdd.2017.5 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Original Paper
Palazzo, Elisabetta
Kellett, Meghan D
Cataisson, Christophe
Bible, Paul W
Bhattacharya, Shreya
Sun, Hong-wei
Gormley, Anna C
Yuspa, Stuart H
Morasso, Maria I
A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation
title A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation
title_full A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation
title_fullStr A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation
title_full_unstemmed A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation
title_short A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation
title_sort novel dlx3–pkc integrated signaling network drives keratinocyte differentiation
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384032/
https://www.ncbi.nlm.nih.gov/pubmed/28186503
http://dx.doi.org/10.1038/cdd.2017.5
work_keys_str_mv AT palazzoelisabetta anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT kellettmeghand anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT cataissonchristophe anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT biblepaulw anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT bhattacharyashreya anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT sunhongwei anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT gormleyannac anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT yuspastuarth anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT morassomariai anoveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT palazzoelisabetta noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT kellettmeghand noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT cataissonchristophe noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT biblepaulw noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT bhattacharyashreya noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT sunhongwei noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT gormleyannac noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT yuspastuarth noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation
AT morassomariai noveldlx3pkcintegratedsignalingnetworkdriveskeratinocytedifferentiation